Advertisement

Topics

StimLabs Announces Partnership with American Military Medical Organization, LLC

08:13 EDT 1 Aug 2017 | PR Newswire

ROSWELL, Ga., Aug. 1, 2017 /PRNewswire/ -- StimLabs, LLC, a leader in regenerative technologies and products that are revolutionizing patient care, is pleased to announce a partnership with the American Military Medical Organization, LLC (AMMO), a leading provider of cost effective, quality products for the federal healthcare marketplace. AMMO is a Veteran Owned Small Business (VOSB) with considerable experience in military medicine and veterans' healthcare. Effective immediately, this partnership enables Veterans Affairs hospitals and Department of Defense facilities to access the complete portfolio of StimLabs' products.

"We are excited to partner with the American Military Medical Organization to serve our customers in U.S. government facilities," said John Daniel, Founder and CEO of StimLabs. "As a veteran myself, it is extremely important that we align with a company like AMMO to distribute our products to active-duty military and veterans who have served so well."

"StimLabs is just the type of company AMMO chooses to partner with to provide products and services to the Federal and VA healthcare market" said William Fallon MD, MBA, President & CEO of AMMO.  "As a former VA chief of surgery and VISN surgical consultant, we are always searching for quality products to enhance the care and outcomes of our military and veterans.  No mission is greater than that to honor their service."

About StimLabs

StimLabs, LLC, was founded in 2015 with a desire to advance the state of regenerative medicine. Within a year of its inception, StimLabs built and certified an ISO Class 7 clean room facility, conceptualized and launched a suite of amniotic-derived products, developed an extensive product pipeline across a range of clinical applications, and established a portfolio of intellectual property. StimLabs portfolio of products includes Ascent™, a shelf-stable injectable amniotic fluid allograft, and Revita®, an intact human placental membrane allograft that preserves all layers of the native tissue in a shelf-stable format. These groundbreaking products apply to a wide range of clinical applications and provide a foundation on which StimLabs is developing new regenerative technologies at the intersection of pharmaceuticals, medical devices, and tissue transplants. For more information, visit www.stimlabs.com.

About AMMO

The American Military Medical Organization is a Center for Veterans Enterprise (CVE) verified VOSB. Their mission is to provide the highest quality and most cost effective medical devices and supplies to healthcare providers. For more information, visit www.ammomedicalsupply.com.

Contact Chas Harris
1225 Northmeadow Parkway  
Suite 104
Roswell, GA  30076
chas@stimlabs.com  
www.stimlabs.com

View original content:http://www.prnewswire.com/news-releases/stimlabs-announces-partnership-with-american-military-medical-organization-llc-300497570.html

SOURCE StimLabs

NEXT ARTICLE

More From BioPortfolio on "StimLabs Announces Partnership with American Military Medical Organization, LLC"

Quick Search
Advertisement
 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...